TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
Thomas Jefferson University
Eilean Therapeutics
National Cancer Institute (NCI)
University of Alabama at Birmingham
University of Turin, Italy
Ohio State University Comprehensive Cancer Center
University of Rochester
City of Hope Medical Center
Center for International Blood and Marrow Transplant Research
Novartis
University of Washington
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
City of Hope Medical Center
Massachusetts General Hospital
Dartmouth-Hitchcock Medical Center
Center for International Blood and Marrow Transplant Research
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
City of Hope Medical Center
City of Hope Medical Center
Incyte Corporation
Thomas Jefferson University
Thomas Jefferson University
Incyte Corporation
Mayo Clinic
Constellation Pharmaceuticals
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Hangzhou GluBio Pharmaceutical Co., Ltd.
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
American Regent, Inc.
City of Hope Medical Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
University of Virginia
M.D. Anderson Cancer Center
University of Rochester
Fred Hutchinson Cancer Center
City of Hope Medical Center
AbbVie